Satellos Bioscience's total assets for Q1 2024 were C$38.26M, a decrease of -13.64% from the previous quarter. MSCLF total liabilities were C$3.75M for the fiscal quarter, a 3.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.